PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Dec-2024 KADANS SCIENCE PARTNER WELCOMES FRESHCHECK TO THE LONDON INNOVATION CENTRE, CANARY WHARF Kadans Science Partner
03-Dec-2024 Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing Smart Immune
03-Dec-2024 Eckert & Ziegler: Changes in the Executive Board and Supervisory Board Eckert & Ziegler SE
03-Dec-2024 Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights. Viromed Medical AG
03-Dec-2024 Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Everest Medicines
02-Dec-2024 Gerresheimer builds new production capacities for glass syringes at Skopje site  Gerresheimer AG
02-Dec-2024 BIO INX Announces the Launch of BIORES INX: A Groundbreaking Gelatin-Based DLP Resin for Bioprinting BIO INX
02-Dec-2024 Announcement of New CEO Appointment Mentice
02-Dec-2024 Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market UNI-BIO SCIENCE GROUP LIMITED
02-Dec-2024 Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler SE
29-Nov-2024 Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value Viromed Medical AG
29-Nov-2024 Mainz Biomed Announces Stock Split Mainz BioMed N.V.
29-Nov-2024 Evotec announces change in Management Board Evotec SE
29-Nov-2024 Modern Dental Group Announces 2024 Third Quarter Operational Update Modern Dental Group Limited
28-Nov-2024 Asklepios Group: Consistent growth in first nine months of 2024 Asklepios Kliniken
28-Nov-2024 Formycon reports nine-month results for 2024 and continues growth trajectory with further operational successes Formycon AG
27-Nov-2024 Marinomed Biotech AG: Binding Term Sheet for the intended issuance of a convertible bond to the European Investment Bank (EIB) signed Marinomed Biotech AG
27-Nov-2024 Marinomed Biotech AG: Publication of a report on the exclusion of subscription rights for a possible second cash capital in-crease of up to 154,053 shares Marinomed Biotech AG
27-Nov-2024 Grünenthal announces pricing of €500 million bond Grünenthal GmbH
27-Nov-2024 Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler SE